4632419K20Rik Inhibitors
Chemical inhibitors of the protein 4632419K20Rik can exert their effects through various biochemical pathways to disrupt its function. Chloroquine, for instance, can inhibit endosomal acidification, a critical process for the maturation and transport of many proteins. If 4632419K20Rik requires such an acidic environment for its function or localization, chloroquine's interference with endosomal pH would lead to its inhibition. Similarly, Bafilomycin A1, by specifically targeting the vacuolar-type H+-ATPase, can dismantle the proton gradient essential for cellular processes that 4632419K20Rik might rely on. This action would prevent 4632419K20Rik from performing its role if it is dependent on this gradient.
On the molecular signaling front, several inhibitors can affect pathways that potentially involve 4632419K20Rik. LY294002 and Rapamycin target the PI3K/AKT/mTOR pathway, which is crucial for various aspects of cell growth and metabolism. LY294002 can inhibit PI3K, while Rapamycin can impede mTOR, leading to the inhibition of 4632419K20Rik if it operates downstream or within this signaling cascade. Compounds such as SB203580 and U0126 can interrupt the p38 MAPK and MEK/ERK pathways, respectively. If 4632419K20Rik's activity is modulated through these routes, its function would be inhibited by these chemical agents. Additionally, SP600125 can inhibit the JNK signaling pathway, potentially leading to the inhibition of 4632419K20Rik if it is regulated by JNK activity. Moreover, WZ4003, a selective NUAK1 inhibitor, and PF-4708671, a selective inhibitor of the S6 Kinase 1 (S6K1) pathway, can disrupt the function of 4632419K20Rik if its activity is contingent upon these kinases. Lastly, PD98059, a MEK inhibitor, and LDC000067, a CDK9 inhibitor, can lead to inhibition of 4632419K20Rik by interfering with the pathways that are required for its activity, further illustrating the diverse mechanisms by which chemical inhibitors can modulate protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can inhibit the endosomal acidification, which is necessary for some proteins to undergo proper post-translational modification or transport. If 4632419K20Rik requires such acidification for its function, chloroquine's action would result in its functional inhibition. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of the vacuolar-type H+-ATPase. If 4632419K20Rik depends on the proton gradient maintained by this ATPase for its activity, then Bafilomycin A1 would inhibit this protein's function by disrupting the gradient. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 acts as a proteasome inhibitor, preventing the degradation of proteins. If 4632419K20Rik is involved in tagging proteins for degradation, inhibition of the proteasome by MG132 could lead to the functional inhibition of 4632419K20Rik's role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can inhibit the PI3K/AKT/mTOR pathway. If 4632419K20Rik functions downstream or is regulated by this pathway, then LY294002 would result in the functional inhibition of this protein. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is involved in cell growth and proliferation. If the activity of 4632419K20Rik is linked to the mTOR signaling pathway, rapamycin would inhibit the function of 4632419K20Rik by inhibiting this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, and if 4632419K20Rik's function is mediated through the p38 MAPK pathway, this inhibitor would lead to functional inhibition of the protein. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, and if 4632419K20Rik acts downstream of the ERK/MAPK pathway, its function would be inhibited by U0126 through the inhibition of this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, and if the activity of 4632419K20Rik is regulated by the JNK signaling pathway, the use of SP600125 would inhibit the function of 4632419K20Rik by blocking this pathway. | ||||||
WZ8040 | 1214265-57-2 | sc-364656 sc-364656A | 5 mg 10 mg | $255.00 $480.00 | ||
WZ4003 is a selective NUAK1 inhibitor, and if 4632419K20Rik is a substrate or is regulated by NUAK1, its inhibition by WZ4003 would lead to the functional inhibition of 4632419K20Rik. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
PF-4708671 is a selective inhibitor of the S6 Kinase 1 (S6K1) pathway, and if 4632419K20Rik's function is S6K1-dependent, this compound would functionally inhibit 4632419K20Rik. | ||||||